Literature DB >> 12526953

Association between hepatitis C infection and other infectious diseases: a case for targeted screening?

Hashem B El-Serag1, Bhupinderjit Anand, Peter Richardson, Linda Rabeneck.   

Abstract

OBJECTIVE: Hepatitis C virus (HCV) shares risk factors and routes of transmission with several other infectious agents. However, the prevalence of comorbid infectious disorders among HCV-infected patients remains unknown. To analyze the association between HCV and several categories of infectious disorders, we carried out a case-control study using information from 172 hospitals contained in the computerized databases of the Department of Veterans Affairs.
METHODS: We identified all HCV-infected patients who were hospitalized during 1992-1999. For each case, four control subjects without HCV were randomly chosen from hospitalized patients and were matched with cases on the year of admission. The frequencies of several predefined infectious disease diagnoses were compared between cases and control subjects, and the strength of these associations were assessed in multivariable logistic regression analyses.
RESULTS: We identified 34,204 HCV-infected patients (cases) and 136,816 control subjects without HCV. Patients in the case group were younger (48.4 yr vs 59.8 yr), were more frequently nonwhite (38.5% vs 26.5%), and were more likely to have served in Vietnam (68.1% vs 33.0%); all p < 0.0001. Compared with control subjects, patients with HCV had a significantly higher prevalence of other blood-borne virus infections, including HIV (14.1% vs 3.0%) and hepatitis B (22.4% vs 0.7%); immunodeficiency-related infections, including cytomegalovirus (0.6% vs 0.2%), toxoplasmosis (0.3% vs 0.1%), cryptococcosis (0.4% vs 0.1%), and tuberculosis (3.3% vs 1.3%); sexually transmitted diseases, including gonococcus (0.5% vs 0.1%), chlamydia (1.6% vs 0.7%), syphilis (2.0% vs 0.6%), and genital herpes (1.0% vs 0.3%); and bacterial infection, including peritonitis, sepsis, endocarditis, cellulitis, and carbuncles (all p < 0.0001). After excluding potentially immunocompromised patients, including those with HIV, organ transplant, and cirrhosis, HCV remained significantly associated with CMV, cryptococcus, tuberculosis, and sexually transmitted diseases. Similar results were obtained when the analyses were restricted to Vietnam-era veterans.
CONCLUSIONS: Several infectious diseases are more common among HCV-infected patients compared with those without HCV infection. These findings support an approach of targeted screening for HCV among patients with these infectious diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12526953     DOI: 10.1111/j.1572-0241.2003.07176.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  27 in total

1.  Tuberculosis knowledge, perceived risk and risk behaviors among homeless adults: effect of ethnicity and injection drug use.

Authors:  Adeline Nyamathi; Heather Sands; Angela Pattatucci-Aragón; Jill Berg; Barbara Leake
Journal:  J Community Health       Date:  2004-12

2.  Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.

Authors:  Tanya R Flohr; Hugo Bonatti; Tjasa Hranjec; Doug S Keith; Peter I Lobo; Sean C Kumer; Timothy M Schmitt; Robert G Sawyer; Timothy L Pruett; John P Roberts; Kenneth L Brayman
Journal:  J Surg Res       Date:  2011-11-19       Impact factor: 2.192

3.  Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Authors:  Young-Chan Kwon; Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

4.  Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Authors:  Meir Mizrahi; Lilach Roemi; Daniel Shouval; Tomer Adar; Maya Korem; Alon Moses; Alan Bloom; Oren Shibolet
Journal:  World J Hepatol       Date:  2011-05-27

5.  Cryptococcosis in patients living with hepatitis C and B viruses.

Authors:  Fernanda Sá Spies; Markus Berger de Oliveira; Monique Siebra Krug; Cecilia Bittencourt Severo; Luiz Carlos Severo; Marilene Henning Vainstein
Journal:  Mycopathologia       Date:  2014-12-21       Impact factor: 2.574

6.  Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection.

Authors:  Angela Dolganiuc; Catherine Garcia; Karen Kodys; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.

Authors:  J W Baddley; J R Perfect; R A Oster; R A Larsen; G A Pankey; H Henderson; D W Haas; C A Kauffman; R Patel; A K Zaas; P G Pappas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

10.  Epidemiological profile of cryptococcal meningitis patients in Rio Grande do Sul, Brazil.

Authors:  Ana Lusia Leal; Josiane Faganello; Alexandre Meneghello Fuentefria; Juliano Tomazzoni Boldo; Maria Cristina Bassanesi; Marilene H Vainstein
Journal:  Mycopathologia       Date:  2008-04-29       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.